Figure 2

Reasons for not using tolvaptan among ADPKD patients with Mayo Clinic Imaging Classification 1C, 1D, 1E (n = 219). Patient were from the cohort followed primarily or co-managed with their primary nephrologists by the Center for Innovative Management of Polycystic Kidney Disease. ^aUnspecified: No reason provided in the response. ^bConsidering: Patients who are considering tolvaptan but remain undecided. ^cFamily planning: Planning or contemplating pregnancy. ^dAdvanced age: Age ≥60 with perceived reduced benefit of tolvaptan usage. ^eLifestyle: Patients who had refused tolvaptan due to being unable to handle the possible aquaretic effect of the medication due to either their occupation or social circumstances.